rs17742347

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The ENST00000590342.1(DUSP3):​n.*1214G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

DUSP3
ENST00000590342.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.326

Publications

16 publications found
Variant links:
Genes affected
DUSP3 (HGNC:3069): (dual specificity phosphatase 3) The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene maps in a region that contains the BRCA1 locus which confers susceptibility to breast and ovarian cancer. Although DUSP3 is expressed in both breast and ovarian tissues, mutation screening in breast cancer pedigrees and in sporadic tumors was negative, leading to the conclusion that this gene is not BRCA1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000590342.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DUSP3
NM_004090.4
MANE Select
c.*509G>C
3_prime_UTR
Exon 3 of 3NP_004081.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DUSP3
ENST00000590342.1
TSL:1
n.*1214G>C
non_coding_transcript_exon
Exon 4 of 4ENSP00000467424.1
DUSP3
ENST00000226004.8
TSL:1 MANE Select
c.*509G>C
3_prime_UTR
Exon 3 of 3ENSP00000226004.2
DUSP3
ENST00000590342.1
TSL:1
n.*1214G>C
3_prime_UTR
Exon 4 of 4ENSP00000467424.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1192
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
682
African (AFR)
AF:
0.00
AC:
0
AN:
6
American (AMR)
AF:
0.00
AC:
0
AN:
10
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8
East Asian (EAS)
AF:
0.00
AC:
0
AN:
10
South Asian (SAS)
AF:
0.00
AC:
0
AN:
40
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
8
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
612
Other (OTH)
AF:
0.00
AC:
0
AN:
48
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
1542

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.9
DANN
Benign
0.37
PhyloP100
0.33
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17742347; hg19: chr17-41846468; API